🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Apatinib plus XELOX regime as Neoadjuvant Therapy in Locally Advanced Gastr...
Status
Unknown
Location
ZhongShan hospital FuDan university
Start Date
2017-02-01
Trial ID
NCT03229096
Treatments Being Tested
(1) Evaluate the efficacy of apatinib in combination with standard second-l...
Status
Unknown
Location
Multiple Locations
Start Date
2018-02-28
Trial ID
NCT03412994
Treatments Being Tested
To observe and evaluate the efficacy and safety of oxaliplatin with oapecit...
Status
Unknown
Location
Anhui Provincial Cancer Hospital
Start Date
2018-09-01
Trial ID
NCT03599778
Treatments Being Tested
This is a randomized, multicenter, controlled study to compared the Efficac...
Status
Unknown
Location
Multiple Locations
Start Date
2017-12-20
Trial ID
NCT03355612
In this clinical study, investigators explore the efficacy and safety of a ...
Status
Completed
Location
Renmin hosptial of Wuhan University
Start Date
2021-03-01
Trial ID
NCT06238752
Treatments Being Tested
Immunotherapy combined with chemotherapy has become the standard first-line...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2025-06-15
Trial ID
NCT07294664
The main purpose of this study is to evaluate whether the Apatinib can impr...
Status
Unknown
Location
Department of Gastrointestinal Medical Oncology, Tianjin Medical University Cancer Hospital
Start Date
2016-04
Trial ID
NCT02776527
Treatments Being Tested
This project is a prospective, multi-center, multi-cohort exploratory clini...
Status
Recruiting
Location
China Pharmaceutical University Affiliated Nanjing Tianyinshan Hospital
Start Date
2025-05-22
Trial ID
NCT06893887
This study is a prospective, umbrella-design, Phase II clinical trial. Elig...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-01
Trial ID
NCT06881017
To evaluate the safety of karillizumab combined with apatinib mesylate, XEL...
Status
Unknown
Location
Zhongshan Hospital Xiamen University
Start Date
2020-03-01
Trial ID
NCT04202978
Treatments Being Tested